Internal Medicine, Endocrinology, Diabetes, & Metabolism · Haverhill, MA
NPI
1043304249
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
62 Brown St, Suite 303
Haverhill, MA, 01830
Phone (978) 478-5030
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
487 services
Medicare patients, 2024
294
Average age 72
Drug cost, 2024
$2.3M
3,985 prescriptions
Company payments, 2024
$31.16
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Neil D Ravin was code 99214 (office e&m - established), 197 times for 145 patients. In total Neil D Ravin billed 487 services in 9 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 197 | 145 | $81.84 | $16K |
| 99214 Office E&M - Established | Facility | 169 | 134 | $67.49 | $11K |
| 99443 Telephone Services | Office | 52 | 39 | $80.80 | $4,201 |
| 99213 Office E&M - Established | Office | 18 | 18 | $72.42 | $1,304 |
| 99213 Office E&M - Established | Facility | 15 | 15 | $50.99 | $765 |
| 99204 Office E&M - New | Facility | 14 | 14 | $97.64 | $1,367 |
| 99204 Office E&M - New | Office | 11 | 11 | $119.45 | $1,314 |
By year: 2022 $42K for 503 services; 2023 $39K for 490 services; 2024 $37K for 487 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 20 | 19 | $9.07 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Neil D Ravin prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 378 prescriptions and refills. In total Neil D Ravin wrote 3,985 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 378 | 609 | 95 | $652K |
| Levothyroxine Sodium Generic | 372 | 1,076 | 99 | $3,778 |
| Metformin Hcl Generic | 362 | 1,003 | 104 | $2,569 |
| Farxiga Dapagliflozin Propanediol | 300 | 670 | 73 | $365K |
| Jardiance Empagliflozin | 241 | 595 | 65 | $334K |
| Glimepiride Generic | 169 | 452 | 49 | $1,516 |
| Trulicity Dulaglutide | 136 | 266 | 35 | $259K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 119 | 227 | 28 | $20K |
| Ozempic Semaglutide | 113 | 213 | 28 | $191K |
| Metformin Hcl Er Metformin Hcl | 96 | 291 | 30 | $1,081 |
| Novolin N Insulin Nph Human Isophane | 96 | 183 | 25 | $21K |
| Humulin N Kwikpen Insulin Nph Human Isophane | 91 | 201 | 28 | $29K |
| Atorvastatin Calcium Generic | 86 | 255 | 31 | $815 |
| Testosterone Cypionate Generic | 84 | 91 | 13 | $1,760 |
| Glipizide Generic | 84 | 225 | 26 | $690 |
Brand drugs: 2,196 claims; generic drugs: 1,521 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Neil D Ravin $31.16 ($31.16 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbott Laboratories with $16.98.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.